| Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires AJ Brown, I Snapkov, R Akbar, M Pavlović, E Miho, GK Sandve, V Greiff Molecular Systems Design & Engineering 4 (4), 701-736, 2019 | 28 | 2019 |
| The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis I Snapkov, CO Öqvist, Y Figenschau, P Kogner, JI Johnsen, ... BMC cancer 16 (1), 1-12, 2016 | 26 | 2016 |
| Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo C Tümmler, I Snapkov, M Wickström, U Moens, L Ljungblad, LHM Elfman, ... Oncotarget 8 (56), 95135, 2017 | 23 | 2017 |
| Agnoprotein of polyomavirus BK interacts with proliferating cell nuclear antigen and inhibits DNA replication N Gerits, M Johannessen, C Tümmler, M Walquist, S Kostenko, I Snapkov, ... Virology journal 12 (1), 1-14, 2015 | 23 | 2015 |
| A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding R Akbar, PA Robert, M Pavlović, JR Jeliazkov, I Snapkov, A Slabodkin, ... Cell Reports 34 (11), 108856, 2021 | 13 | 2021 |
| immuneSIM: tunable multi-feature simulation of B-and T-cell receptor repertoires for immunoinformatics benchmarking CR Weber, R Akbar, A Yermanos, M Pavlović, I Snapkov, GK Sandve, ... Bioinformatics 36 (11), 3594-3596, 2020 | 13 | 2020 |
| Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients. Clin Epidemiol. 2018 Aug 6; 10: 931–940 E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden | 5 | |
| Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ... Clinical epidemiology 10, 931, 2018 | 3 | 2018 |
| FITC conjugation markedly enhances hepatic clearance of N-formyl peptides CI Øie, I Snapkov, K Elvevold, B Sveinbjørnsson, B Smedsrød PloS one 11 (8), e0160602, 2016 | 3 | 2016 |
| A finite vocabulary of antibody-antigen interaction enables predictability of paratope-epitope binding R Akbar, JR Jeliazkov, PA Robert, I Snapkov, M Pavlović, A Slabodkin, ... bioRxiv, 759498, 2019 | 2 | 2019 |
| The Future of Blood Testing Is the Immunome RA Arnaout, ETL Prak, N Schwab, F Rubelt Frontiers in immunology 12, 2021 | 1 | 2021 |
| Breast cancer women lack normal immune response after full-term pregnancies. E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ... Norsk Epidemiologi 28, 2018 | 1 | 2018 |
| The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis I Snapkov, CO Öqvist, YA Figenschau, P Kogner, JI Johnsen, ... Cancer Research 75 (15 Supplement), 3283-3283, 2015 | 1 | 2015 |
| Expression of chemerin and chemerin receptors in neuroblastoma: implications in tumorigenesis C Tuemmler, I Snapkov, UL Moens, P Kogner, JI Johnsen, ... Cancer Research 75 (15 Supplement), 3279-3279, 2015 | 1 | 2015 |
| immuneML: an ecosystem for machine learning analysis of adaptive immune receptor repertoires M Pavlovic, L Scheffer, K Motwani, C Kanduri, R Kompova, N Vazov, ... bioRxiv, 2021 | | 2021 |
| Deciphering the complexity of immune repertoires using systems immunology and machine learning V Greiff, R Akbar, M Pavlovic, CR Weber, I Snapkov, ST Reddy, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 1998-1998, 2019 | | 2019 |
| Transcriptional profiles of whole blood from women with ovarian cancer. A prospective nested case-control study from the NOWAC Post-genome Cohort. M Jareid, I Snapkov, M Holden, TH Nøst, E Lund Norsk Epidemiologi 28, 2018 | | 2018 |
| Expression of formyl peptide receptor 1 (FPR1) in neuroblastoma: Implications in tumorigenesis I Snapkov, P Kogner, JI Johnsen, B Sveinbjørnsson Cancer Research 74 (19 Supplement), 3976-3976, 2014 | | 2014 |
| Chemerin and chemerin receptors in neuroblastoma tumor microenvironment C Tuemmler, I Snapkov, UL Moens, B Sveinbjørnsson Cancer Research 74 (19 Supplement), 3990-3990, 2014 | | 2014 |
| Transcription factor PAX6 is expressed in human soft tissue sarcomas and confers negative impact on patients' survival Y Kiselev, A Valkov, I Mikkola, I Snapkov, S Sorbye, R Bremnes, ... Cancer Research 74 (19 Supplement), 4722-4722, 2014 | | 2014 |
